Claims for Patent: 8,729,027
✉ Email this page to a colleague
Summary for Patent: 8,729,027
Title: | Therapeutic agent for fibromyalgia containing etanercept |
Abstract: | Disclosed is a drug effective in the treatment of fibromyalgia. Basically, the disclosed therapeutic agent was created on the basis of experiments showing improvement in symptoms when etanercept was administered to patients suffering from fibromyalgia. Etanercept is known as a therapeutic agent for rheumatoid arthritis, and the JFIQ score of patients not suffering from fibromyalgia improved considerably in the preferred embodiment. In other words, a therapeutic agent for fibromyalgia is disclosed that contains etanercept as an active ingredient in an effective amount. |
Inventor(s): | Nishioka; Kusuki (Tokyo, JP) |
Assignee: | AXIS Inc. (Kagoshima, JP) |
Application Number: | 13/808,291 |
Patent Claims: | 1. A method of treating a patient who suffers from fibromyalgia, the method comprising a step of administering an agent comprising etanercept as an active ingredient
in an effective amount to the patient, wherein the patient does not suffer from rheumatism.
2. The method in accordance with claim 1, wherein the agent has a dosage form of an injectable preparation. 3. The method in accordance with claim 1, the agent is administered to ameliorate at least one symptom associated with fibromyalgia selected from the group consisting of a feeling of fatigability, sleep disorder, body temperature abnormality, numbness in a hand or a foot, numbness in arms and legs, excess sweating, a depressed condition, car sickness, and menstrual irregularity. |
Details for Patent 8,729,027
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2030-07-05 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2030-07-05 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 09/27/2004 | ⤷ Try a Trial | 2030-07-05 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.